New features deliver additional sizes, sterilisation/sanitisation compatibility
ACHIEVING high product purity early in the manufacturing process and improving efficiency and economics is important to biopharmaceutical manufacturers. Increasing removal of impurities like DNA and HCP during clarification improves the performance of downstream capture and polishing steps. The 3M Emphaze AEX Hybrid Purifier meet these challenges through reduction of cell debris, DNA and HCP at clarification to help improve downstream process steps, promises the developer. The new Emphaze capsules are sterilisation/ sanitisation compatible and can be used across various aqueous based biopharmaceutical processes, including vaccine purification. Additionally, the improved Emphaze AEX Hybrid Purifier products now feature two new laboratory capsules and one scale-up capsule that allows evaluations at laboratory and scale-up volumes.
Emphaze AEX Hybrid Purifier products combine three unique 3M technologies – advanced polymer materials, fine fibre nonwovens, and membranes
– to deliver a synthetic clarifying product line containing a novel anion exchange nonwoven media and a fine particle, reduction membrane.